401k Plan data: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN plan

SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 401k Plan overview

Plan Name	SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN
Plan identification number	001

SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

SYNAGEVA BIOPHARMA CORP. has sponsored the creation of one or more 401k plans.

Company Name: SYNAGEVA BIOPHARMA CORP.

Employer identification number (EIN): 943244869

NAIC Classification: 325410

Additional information about SYNAGEVA BIOPHARMA CORP.

Jurisdiction of Incorporation: State of Delaware Division of Corporations

Incorporation Date:

Company Identification Number: 2321814

More information about SYNAGEVA BIOPHARMA CORP.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2015-01-01 KATIE ARCHER
001 2014-01-01 MELISSA MANNO
001 2014-01-01 MELISSA MANNO
001 2013-01-01 MELISSA MANNO
001 2012-01-01 STEPHEN ANDRE STEPHEN ANDRE 2013-10-11
001 2011-01-01 STEPHEN ANDRE
001 2009-01-01 KATHY DOHERTY

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
001	2015-01-01	KATIE ARCHER
001	2014-01-01	MELISSA MANNO
001	2014-01-01	MELISSA MANNO
001	2013-01-01	MELISSA MANNO
001	2012-01-01	STEPHEN ANDRE	STEPHEN ANDRE	2013-10-11
001	2011-01-01	STEPHEN ANDRE
001	2009-01-01	KATHY DOHERTY

Plan Statistics for SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN

401k plan membership statisitcs for SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN

Measure Date Value
2015: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 279
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 0
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 0
Total of all active and inactive participants 2015-01-01 0
Total participants 2015-01-01 0
Number of participants with account balances 2015-01-01 0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 131
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 222
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 57
Total of all active and inactive participants 2014-01-01 279
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 279
Number of participants with account balances 2014-01-01 264
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 0
2013: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 90
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 99
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 32
Total of all active and inactive participants 2013-01-01 131
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 131
Number of participants with account balances 2013-01-01 130
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 0
2012: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 87
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 72
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 18
Total of all active and inactive participants 2012-01-01 90
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 90
Number of participants with account balances 2012-01-01 78
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 0
2011: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 69
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 67
Number of retired or separated participants receiving benefits 2011-01-01 0
Number of other retired or separated participants entitled to future benefits 2011-01-01 20
Total of all active and inactive participants 2011-01-01 87
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2011-01-01 0
Total participants 2011-01-01 87
Number of participants with account balances 2011-01-01 75
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 0
2009: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 67
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 43
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 16
Total of all active and inactive participants 2009-01-01 59
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 59
Number of participants with account balances 2009-01-01 51
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 0

Measure	Date	Value
2015: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	279
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	0
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	0
Total of all active and inactive participants	2015-01-01	0
Total participants	2015-01-01	0
Number of participants with account balances	2015-01-01	0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	131
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	222
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	57
Total of all active and inactive participants	2014-01-01	279
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	279
Number of participants with account balances	2014-01-01	264
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	0
2013: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	90
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	99
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	32
Total of all active and inactive participants	2013-01-01	131
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	131
Number of participants with account balances	2013-01-01	130
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	0
2012: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	87
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	72
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	18
Total of all active and inactive participants	2012-01-01	90
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	90
Number of participants with account balances	2012-01-01	78
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	0
2011: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	69
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	67
Number of retired or separated participants receiving benefits	2011-01-01	0
Number of other retired or separated participants entitled to future benefits	2011-01-01	20
Total of all active and inactive participants	2011-01-01	87
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2011-01-01	0
Total participants	2011-01-01	87
Number of participants with account balances	2011-01-01	75
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	0
2009: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	67
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	43
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	16
Total of all active and inactive participants	2009-01-01	59
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	59
Number of participants with account balances	2009-01-01	51
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	0

Financial Data on SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN

Measure	Date	Value
2015 : SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2015 401k financial data
Unrealized appreciation/depreciation of real estate assets	2015-10-23	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2015-10-23	$0
Total unrealized appreciation/depreciation of assets	2015-10-23	$0
Total transfer of assets to this plan	2015-10-23	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-10-23	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-10-23	$0
Expenses. Interest paid	2015-10-23	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2015-10-23	$0
Total income from all sources (including contributions)	2015-10-23	$2,782,039
Total loss/gain on sale of assets	2015-10-23	$0
Total of all expenses incurred	2015-10-23	$9,559,690
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-10-23	$9,536,433
Expenses. Certain deemed distributions of participant loans	2015-10-23	$0
Value of total corrective distributions	2015-10-23	$7,295
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-10-23	$3,057,418
Value of total assets at end of year	2015-10-23	$0
Value of total assets at beginning of year	2015-10-23	$6,777,651
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-10-23	$15,962
Total income from rents	2015-10-23	$0
Total interest from all sources	2015-10-23	$2,661
Total dividends received (eg from common stock, registered investment company shares)	2015-10-23	$153,527
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-10-23	Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2015-10-23	$0
Total dividends received from registered investment company shares (eg mutual funds)	2015-10-23	$153,527
Assets. Real estate other than employer real property at end of year	2015-10-23	$0
Assets. Real estate other than employer real property at beginning of year	2015-10-23	$0
Administrative expenses professional fees incurred	2015-10-23	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2015-10-23	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2015-10-23	$0
Was this plan covered by a fidelity bond	2015-10-23	Yes
Value of fidelity bond cover	2015-10-23	$100,000
If this is an individual account plan, was there a blackout period	2015-10-23	No
Were there any nonexempt tranactions with any party-in-interest	2015-10-23	No
Contributions received from participants	2015-10-23	$1,480,105
Participant contributions at end of year	2015-10-23	$0
Participant contributions at beginning of year	2015-10-23	$33,629
Participant contributions at end of year	2015-10-23	$0
Participant contributions at beginning of year	2015-10-23	$0
Assets. Other investments not covered elsewhere at end of year	2015-10-23	$0
Assets. Other investments not covered elsewhere at beginning of year	2015-10-23	$0
Income. Received or receivable in cash from other sources (including rollovers)	2015-10-23	$886,423
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2015-10-23	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2015-10-23	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2015-10-23	$0
Assets. Loans (other than to participants) at end of year	2015-10-23	$0
Assets. Loans (other than to participants) at beginning of year	2015-10-23	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2015-10-23	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2015-10-23	$0
Other income not declared elsewhere	2015-10-23	$0
Administrative expenses (other) incurred	2015-10-23	$15,962
Liabilities. Value of operating payables at end of year	2015-10-23	$0
Liabilities. Value of operating payables at beginning of year	2015-10-23	$0
Total non interest bearing cash at end of year	2015-10-23	$0
Total non interest bearing cash at beginning of year	2015-10-23	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-10-23	No
Income. Non cash contributions	2015-10-23	$0
Value of net income/loss	2015-10-23	$-6,777,651
Value of net assets at end of year (total assets less liabilities)	2015-10-23	$0
Value of net assets at beginning of year (total assets less liabilities)	2015-10-23	$6,777,651
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-10-23	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-10-23	No
Were any leases to which the plan was party in default or uncollectible	2015-10-23	No
Assets. partnership/joint venture interests at end of year	2015-10-23	$0
Assets. partnership/joint venture interests at beginning of year	2015-10-23	$0
Investment advisory and management fees	2015-10-23	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-10-23	$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-10-23	$6,718,975
Value of interest in pooled separate accounts at end of year	2015-10-23	$0
Value of interest in pooled separate accounts at beginning of year	2015-10-23	$0
Interest on participant loans	2015-10-23	$2,660
Income. Interest from loans (other than to participants)	2015-10-23	$0
Interest earned on other investments	2015-10-23	$0
Income. Interest from US Government securities	2015-10-23	$0
Income. Interest from corporate debt instruments	2015-10-23	$0
Value of interest in master investment trust accounts at end of year	2015-10-23	$0
Value of interest in master investment trust accounts at beginning of year	2015-10-23	$0
Value of interest in common/collective trusts at end of year	2015-10-23	$0
Value of interest in common/collective trusts at beginning of year	2015-10-23	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2015-10-23	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2015-10-23	$25,047
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2015-10-23	$25,047
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2015-10-23	$1
Assets. Value of investments in 103.12 investment entities at end of year	2015-10-23	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2015-10-23	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2015-10-23	$0
Asset value of US Government securities at end of year	2015-10-23	$0
Asset value of US Government securities at beginning of year	2015-10-23	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-10-23	$-431,567
Net investment gain/loss from pooled separate accounts	2015-10-23	$0
Net investment gain or loss from common/collective trusts	2015-10-23	$0
Net gain/loss from 103.12 investment entities	2015-10-23	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-10-23	No
Was there a failure to transmit to the plan any participant contributions	2015-10-23	Yes
Has the plan failed to provide any benefit when due under the plan	2015-10-23	No
Assets. Invements in employer securities at end of year	2015-10-23	$0
Assets. Invements in employer securities at beginning of year	2015-10-23	$0
Assets. Value of employer real property at end of year	2015-10-23	$0
Assets. Value of employer real property at beginning of year	2015-10-23	$0
Contributions received in cash from employer	2015-10-23	$690,890
Employer contributions (assets) at end of year	2015-10-23	$0
Employer contributions (assets) at beginning of year	2015-10-23	$0
Income. Dividends from preferred stock	2015-10-23	$0
Income. Dividends from common stock	2015-10-23	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-10-23	$9,536,433
Asset. Corporate debt instrument preferred debt at end of year	2015-10-23	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2015-10-23	$0
Asset. Corporate debt instrument debt (other) at end of year	2015-10-23	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2015-10-23	$0
Contract administrator fees	2015-10-23	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2015-10-23	No
Assets. Corporate common stocks other than exployer securities at end of year	2015-10-23	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2015-10-23	$0
Liabilities. Value of benefit claims payable at end of year	2015-10-23	$0
Liabilities. Value of benefit claims payable at beginning of year	2015-10-23	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2015-10-23	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2015-10-23	$0
Did the plan have assets held for investment	2015-10-23	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-10-23	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-10-23	Yes
Aggregate proceeds on sale of assets	2015-10-23	$0
Aggregate carrying amount (costs) on sale of assets	2015-10-23	$0
Liabilities. Value of acquisition indebtedness at end of year	2015-10-23	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2015-10-23	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-10-23	Yes
Opinion of an independent qualified public accountant for this plan	2015-10-23	Disclaimer
Accountancy firm name	2015-10-23	STOWE & DEGON LLC
Accountancy firm EIN	2015-10-23	043379904
2014 : SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2014 401k financial data
Unrealized appreciation/depreciation of real estate assets	2014-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2014-12-31	$0
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total transfer of assets to this plan	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Expenses. Interest paid	2014-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$3,356,823
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$556,362
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$535,513
Expenses. Certain deemed distributions of participant loans	2014-12-31	$0
Value of total corrective distributions	2014-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$3,045,646
Value of total assets at end of year	2014-12-31	$6,777,651
Value of total assets at beginning of year	2014-12-31	$3,977,190
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$20,849
Total income from rents	2014-12-31	$0
Total interest from all sources	2014-12-31	$1,379
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$358,835
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$358,835
Assets. Real estate other than employer real property at end of year	2014-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2014-12-31	$0
Administrative expenses professional fees incurred	2014-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2014-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2014-12-31	$0
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$100,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$1,790,014
Participant contributions at end of year	2014-12-31	$33,629
Participant contributions at beginning of year	2014-12-31	$3,967
Participant contributions at end of year	2014-12-31	$0
Participant contributions at beginning of year	2014-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2014-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2014-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$320,904
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2014-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2014-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2014-12-31	$0
Assets. Loans (other than to participants) at end of year	2014-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2014-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2014-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2014-12-31	$0
Other income not declared elsewhere	2014-12-31	$0
Administrative expenses (other) incurred	2014-12-31	$20,849
Liabilities. Value of operating payables at end of year	2014-12-31	$0
Liabilities. Value of operating payables at beginning of year	2014-12-31	$0
Total non interest bearing cash at end of year	2014-12-31	$0
Total non interest bearing cash at beginning of year	2014-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Income. Non cash contributions	2014-12-31	$0
Value of net income/loss	2014-12-31	$2,800,461
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$6,777,651
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$3,977,190
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Assets. partnership/joint venture interests at end of year	2014-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2014-12-31	$0
Investment advisory and management fees	2014-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$6,718,975
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$3,959,522
Value of interest in pooled separate accounts at end of year	2014-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$0
Interest on participant loans	2014-12-31	$1,376
Income. Interest from loans (other than to participants)	2014-12-31	$0
Interest earned on other investments	2014-12-31	$0
Income. Interest from US Government securities	2014-12-31	$0
Income. Interest from corporate debt instruments	2014-12-31	$0
Value of interest in master investment trust accounts at end of year	2014-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2014-12-31	$0
Value of interest in common/collective trusts at end of year	2014-12-31	$0
Value of interest in common/collective trusts at beginning of year	2014-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2014-12-31	$25,047
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2014-12-31	$13,701
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2014-12-31	$13,701
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2014-12-31	$3
Assets. Value of investments in 103.12 investment entities at end of year	2014-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2014-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2014-12-31	$0
Asset value of US Government securities at end of year	2014-12-31	$0
Asset value of US Government securities at beginning of year	2014-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$-49,037
Net investment gain/loss from pooled separate accounts	2014-12-31	$0
Net investment gain or loss from common/collective trusts	2014-12-31	$0
Net gain/loss from 103.12 investment entities	2014-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Assets. Invements in employer securities at end of year	2014-12-31	$0
Assets. Invements in employer securities at beginning of year	2014-12-31	$0
Assets. Value of employer real property at end of year	2014-12-31	$0
Assets. Value of employer real property at beginning of year	2014-12-31	$0
Contributions received in cash from employer	2014-12-31	$934,728
Employer contributions (assets) at end of year	2014-12-31	$0
Employer contributions (assets) at beginning of year	2014-12-31	$0
Income. Dividends from preferred stock	2014-12-31	$0
Income. Dividends from common stock	2014-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$535,513
Asset. Corporate debt instrument preferred debt at end of year	2014-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2014-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2014-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2014-12-31	$0
Contract administrator fees	2014-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2014-12-31	No
Assets. Corporate common stocks other than exployer securities at end of year	2014-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2014-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2014-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2014-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2014-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2014-12-31	$0
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Aggregate proceeds on sale of assets	2014-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2014-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2014-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2014-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	STOWE & DEGON LLC
Accountancy firm EIN	2014-12-31	043379904
2013 : SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2013 401k financial data
Transfers to/from the plan	2013-12-31	$0
Total plan liabilities at end of year	2013-12-31	$0
Total income from all sources	2013-12-31	$1,979,920
Expenses. Total of all expenses incurred	2013-12-31	$593,425
Benefits paid (including direct rollovers)	2013-12-31	$589,368
Total plan assets at end of year	2013-12-31	$3,977,190
Total plan assets at beginning of year	2013-12-31	$2,590,695
Value of fidelity bond covering the plan	2013-12-31	$100,000
Total contributions received or receivable from participants	2013-12-31	$863,644
Expenses. Other expenses not covered elsewhere	2013-12-31	$0
Contributions received from other sources (not participants or employers)	2013-12-31	$26,955
Other income received	2013-12-31	$638,334
Noncash contributions received	2013-12-31	$0
Net income (gross income less expenses)	2013-12-31	$1,386,495
Net plan assets at end of year (total assets less liabilities)	2013-12-31	$3,977,190
Net plan assets at beginning of year (total assets less liabilities)	2013-12-31	$2,590,695
Assets. Value of participant loans	2013-12-31	$3,967
Total contributions received or receivable from employer(s)	2013-12-31	$450,987
Value of certain deemed distributions of participant loans	2013-12-31	$0
Value of corrective distributions	2013-12-31	$0
Expenses. Administrative service providers (salaries,fees and commissions)	2013-12-31	$4,057
2012 : SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2012 401k financial data
Total income from all sources	2012-12-31	$1,184,875
Expenses. Total of all expenses incurred	2012-12-31	$547,936
Benefits paid (including direct rollovers)	2012-12-31	$547,605
Total plan assets at end of year	2012-12-31	$2,590,695
Total plan assets at beginning of year	2012-12-31	$1,953,756
Value of fidelity bond covering the plan	2012-12-31	$100,000
Total contributions received or receivable from participants	2012-12-31	$426,372
Contributions received from other sources (not participants or employers)	2012-12-31	$267,330
Other income received	2012-12-31	$262,634
Net income (gross income less expenses)	2012-12-31	$636,939
Net plan assets at end of year (total assets less liabilities)	2012-12-31	$2,590,695
Net plan assets at beginning of year (total assets less liabilities)	2012-12-31	$1,953,756
Assets. Value of participant loans	2012-12-31	$81,184
Total contributions received or receivable from employer(s)	2012-12-31	$228,539
Expenses. Administrative service providers (salaries,fees and commissions)	2012-12-31	$331
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
2011 : SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2011 401k financial data
Total income from all sources	2011-12-31	$416,447
Expenses. Total of all expenses incurred	2011-12-31	$436,110
Benefits paid (including direct rollovers)	2011-12-31	$435,082
Total plan assets at end of year	2011-12-31	$1,953,756
Total plan assets at beginning of year	2011-12-31	$1,973,419
Value of fidelity bond covering the plan	2011-12-31	$100,000
Total contributions received or receivable from participants	2011-12-31	$312,013
Contributions received from other sources (not participants or employers)	2011-12-31	$18,891
Other income received	2011-12-31	$-93,224
Net income (gross income less expenses)	2011-12-31	$-19,663
Net plan assets at end of year (total assets less liabilities)	2011-12-31	$1,953,756
Net plan assets at beginning of year (total assets less liabilities)	2011-12-31	$1,973,419
Assets. Value of participant loans	2011-12-31	$44,881
Total contributions received or receivable from employer(s)	2011-12-31	$178,767
Expenses. Administrative service providers (salaries,fees and commissions)	2011-12-31	$1,028
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2011-12-31	$0
2010 : SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2010 401k financial data
Total income from all sources	2010-12-31	$625,698
Expenses. Total of all expenses incurred	2010-12-31	$54,978
Benefits paid (including direct rollovers)	2010-12-31	$54,785
Total plan assets at end of year	2010-12-31	$1,973,419
Total plan assets at beginning of year	2010-12-31	$1,402,699
Value of fidelity bond covering the plan	2010-12-31	$100,000
Total contributions received or receivable from participants	2010-12-31	$256,260
Other income received	2010-12-31	$234,694
Net income (gross income less expenses)	2010-12-31	$570,720
Net plan assets at end of year (total assets less liabilities)	2010-12-31	$1,973,419
Net plan assets at beginning of year (total assets less liabilities)	2010-12-31	$1,402,699
Assets. Value of participant loans	2010-12-31	$12,008
Total contributions received or receivable from employer(s)	2010-12-31	$134,744
Expenses. Administrative service providers (salaries,fees and commissions)	2010-12-31	$193
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2010-12-31	$0
2009 : SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN

2015: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	Yes
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Single employer plan
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan is a collectively bargained plan	No
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2009: SYNAGEVA BIOPHARMA CORP. 401(K) RETIREMENT SAVINGS PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	SYNAGEVA BIOPHARMA CORP.
Employer identification number (EIN):	943244869
NAIC Classification:	325410

Jurisdiction of Incorporation:	State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number:	2321814